In silico docking and molecular dynamics simulation analysis of phytochemicals targeting human metapneumovirus fusion protein
In Silico Pharmacology · 31.07.2026 · 14 (2)
DOI: 10.1007/s40203-026-00716-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Silico Pharmacology, online erschienen am 31.07.2026. Verfasst von Amna Syeda und 2 weiteren Autor:innen. Beteiligte Einrichtung: Applied Research Center for Environment and Marine Studies, Research and Innovation, King Fahd University of Petroleum & Minerals, 31261 Dhahran, Sau…. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Applied Research Center for Environment and Marine Studies, Research and Innovation, King Fahd University of Petroleum & Minerals, 31261 Dhahran, Saudi Arabia.
- Department of Biotechnology, Jamia Millia Islamia, New Delhi, Delhi 110025 India.
- Department of Biosciences, Jamia Millia Islamia, New Delhi, Delhi 110025 India.
- Department of Radiation Oncology, Rutgers Cancer Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901 USA.
ORCID-Profile: Amna Syeda
Zitieren
APA
Syeda, A., Ali, R., & Beg, M. A. (2026). In silico docking and molecular dynamics simulation analysis of phytochemicals targeting human metapneumovirus fusion protein. In Silico Pharmacology, 14(2). https://doi.org/10.1007/s40203-026-00716-2
Vancouver
Syeda A, Ali R, Beg MA. In silico docking and molecular dynamics simulation analysis of phytochemicals targeting human metapneumovirus fusion protein. In Silico Pharmacology. 2026;14(2). doi:10.1007/s40203-026-00716-2
BibTeX
@article{Syeda2026,
author = {Syeda, Amna and Ali, Rafat and Beg, Md Amjad},
title = {In silico docking and molecular dynamics simulation analysis of phytochemicals targeting human metapneumovirus fusion protein},
journal = {In Silico Pharmacology},
year = {2026},
volume = {14},
number = {2},
doi = {10.1007/s40203-026-00716-2}
}
EUVIMED